Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Revenue (2017 - 2025)

Catheter Precision (VTAK) has disclosed Revenue for 9 consecutive years, with $238000.0 as the latest value for Q4 2025.

  • Quarterly Revenue rose 59.73% to $238000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $819000.0 through Dec 2025, up 95.0% year-over-year, with the annual reading at $819000.0 for FY2025, 95.0% up from the prior year.
  • Revenue for Q4 2025 was $238000.0 at Catheter Precision, up from $226000.0 in the prior quarter.
  • The five-year high for Revenue was $1.0 million in Q2 2021, with the low at $4000.0 in Q1 2021.
  • Average Revenue over 5 years is $150777.8, with a median of $96000.0 recorded in 2023.
  • The sharpest move saw Revenue plummeted 99.71% in 2021, then soared 1820.0% in 2023.
  • Over 5 years, Revenue stood at $5000.0 in 2021, then changed by 0.0% to $5000.0 in 2022, then skyrocketed by 2460.0% to $128000.0 in 2023, then rose by 16.41% to $149000.0 in 2024, then soared by 59.73% to $238000.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $238000.0, $226000.0, and $212000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.